Specialties

Clinical trials cover multiple areas of medicine and require the participation of different medical specialties.

Send CV or feasibility form to feasibilities@iic-mardelplata.com.ar


Cardiovascular

Cardiovascular risk and prevention, atrial fibrillation, dyslipidemia, hypertension.

 


Metabolism

Diabetes, obesity, fatty liver disease.


Infectious Diseases

HIV, vaccines, viral hepatitis.


Nephrology

Chronic kidney disease and proteinuria.

 


Neuropsychiatry

Alzheimer's disease, substance use disorders, and related conditions.


Respiratory

Asthma, COPD.

What is a clinical trial?

10 things you should know about a research study



1

1. Clinical trials are the backbone of new drug development. Research studies provide the information needed to determine whether a new medication is effective and safe to use. Without research, there are no new treatments.

2​

Taking part in a clinical trial is an individual, personal decision.

3​

The health of participating patients is the priority of the entire research team.

4​

Pharmacological research studies operate under a strict national and international regulatory and ethical framework that protects patients' safety and rights.

5​

The risk/benefit of participating varies by situation, and researchers only conduct a clinical trial if the potential benefit outweighs the risk.

​

6​

Every research study has clear rules for participation through inclusion and exclusion criteria. The investigating physician assesses which patients can participate based on their condition and characteristics.

7​

All patients taking part in a clinical trial may withdraw at any time they choose.

​

8​

Volunteering involves no cost, and participation is free of charge.

9​

Clinical trials are conducted simultaneously in different countries, under the same standards. To approve a medication for use, it is essential that patients from various cities around the world take part.

10​

Most patients who take part in a clinical trial would consider doing so again. According to a CISCRP survey, 95% would participate again.